A Phase II Trial of the Epothilone B Analog Ixabepilone (BMS-247550) in Patients with Metastatic Melanoma

Overview of attention for article published in PLOS ONE, January 2010

Altmetric Badge

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 28 Mendeley

Summary Dimensions citations

So far, Dimensions has found 8 publications that cite this research output.

8

The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.

Patient Benefit and Risk in Anticancer Drug Development: A Systematic Review of the Ixabepilone Trial Portfolio

Preprint in medRxiv (August 2019)

Discovery and Development of Vemurafenib: First‐in‐Class Inhibitor of Mutant BRAF for the Treatment of Cancer

Book chapter (December 2013)

The Role of Chemotherapy for Metastatic Disease

Book chapter (January 2013)